- Home
- BIOA vs STRW Comparison
BIOA vs STRW Comparison
Compare BIOA & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$12.48
HOLD
Current Price
$13.50
Company Overview
Basic Information| Metric | BIOA | STRW |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.7M | 151.1M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | BIOA | STRW |
|---|---|---|
| Price | $12.48 | $13.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $11.33 | ★ $12.72 |
| AVG Volume (30 Days) | ★ 410.3K | 31.5K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 4.88% |
| EPS Growth | N/A | ★ 19.41 |
| EPS | N/A | ★ 0.61 |
| Revenue | $5,917,000.00 | ★ $145,392,000.00 |
| Revenue This Year | N/A | $35.42 |
| Revenue Next Year | N/A | $7.19 |
| P/E Ratio | ★ N/A | $21.59 |
| Revenue Growth | N/A | ★ 29.76 |
| 52 Week Low | $2.88 | $8.70 |
| 52 Week High | $13.10 | $13.77 |
Technical Indicators
Market Signals| Indicator | BIOA | STRW |
|---|---|---|
| Relative Strength Index (RSI) | 77.17 | 70.26 |
| Support Level | $12.00 | $12.56 |
| Resistance Level | $13.10 | $13.19 |
| Average True Range (ATR) | 0.72 | 0.50 |
| MACD | 0.26 | 0.07 |
| Stochastic Oscillator | 87.28 | 95.54 |
Price Performance
Historical Comparison BIOA
STRW
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.